Glossary Galenica

The Glossary contains explanations for specific terms and expressions used by the Galenica Group as well as terms of the healthcare sector.

Innovative, plant-based dermo-cosmetic brand based on the unique active substance Rhealba® oat. 


TriaPharm® application. Simplifies processes in the goods cycle from ordering to checking incoming goods and expiry dates, and guarantees more reliable inventory levels.


Vifor Pharma’s study to compare Ferric Carboxymaltose with placebo in patients with acute heart failure and iron deficiency (Affirm-AHF).

AHA (American Heart Association)

Annual conference of the American Heart Association. 

AIPS – Drug information publication system

Official Swissmedic drug information publication platform (Arzneimittelinformation Publikationsplattform Swissmedic).


The leading ibuprofen-based OTC analgesic in Switzerland; developed and sold by Vifor Pharma.


Service provided by Amavita and Coop Vitality: injust 20 minutes, customers receive a personal allergy profile for the ten most common respiratory allergy triggers.


An anti-nausea therapeutic medicine for the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy and the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy, in paediatric patients one month of age and older.

Amavita partnership

Franchise system developed by GaleniCare for pharmacists wishing to enjoy the benefits of the Amavita network while retaining their independence.

Ambition Négawatt/éco21

Programme developed by electricity and water supplier SIG (Services Industriels de Genève). The main objective of this programme is to Support companies and private individuals in the Geneva area in reducing their energy consumption and CO2 emissions.

Anaemia, anaemic

A deficiency of red blood cells or haemoglobin in the bloodstream, frequently caused by iron deficiency.


The leading insect repellent spray and lotion in Switzerland, also widely sold in other European countries; a proprietary product of Vifor Pharma.

Swiss Drug Compendium (Arzneimittel-Kompendium der Schweiz®)

A standard reference work for medical professionals that contains extensive technical product information; developed and marketed by HCI Solutions.


Investigation of processes with regard to compliance with requirements and guidelines. The examination is carried out by an external expert such as an FDA inspector or by a representative of an accredited auditing company such as SGS.

Autoimmune disease

The general term for diseases caused by an overreaction of the immune system to the body’s own tissues. In such conditions, the immune system mistakenly perceives the body’s own tissues to be foreign bodies that need to be attacked. This leads to acute inflammation reactions that result in damage to the affected organs.


An active ingredient in medications to suppress the immune system.

Dispensing check

A service provided by pharmacists as defined by the service-based remuneration (SBR) agreement, which requires pharmacists to keep patient files.

Blister pack

A type of packaging that allows the customer to see the packaged product (see-through packaging).

Bolus injection

The administration of a medicine by injection using a syringe.


Biotech drug for the prevention and alleviation of respiratory tract infections; developed and marketed by OM Pharma.

Carbon Disclosure Project (CDP)

An international, non-profit organisation providing the largest and only global environmental database for companies and cities. The aim of CDP is to encourage as many companies as possible to publish data on their impact on the environment and natural resources.


Patch worn on the body to measure physical and mental stress. The measurement is then evaluated by an app. 

Care management

A form of organised assistance given to employees to meet their individual needs in the event of in ability to work due to illness or injury.


An orally-administered inhibitor of the chemokine receptor known as CCR2, for renal diseases. CCX140 has previously completed a successful Phase II clinical trial in patients with diabetic kidney disease. 


A complement 5a inhibitor ready for Phase III development for orphan and rare renal diseases.


A drug developed by Roche for the treatment of rejection reactions following organ transplants. Vifor Pharma holds the global rights (excluding Japan) to develop and market this drug for all applications involving autoimmune diseases.

Change management

All tasks, actions and activities designed to bring about comprehensive and radical change in a company in order to implement new strategies, structures, etc.


The branch of medicine that uses operative manual or instrumental techniques on a patient to treat diseases and injuries.


Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA). The CHMP prepares the opinions of the EMA and deals with the approval and risk assessment of medicines that are used to treat humans and that require EU-wide approval.

Chronic obstructive pulmonary disease (COPD)

Collective term for a group of pulmonary diseases. Sometimes referred to colloquially as “smoker’s lung”.


Clinical Information System: a module that supports electronic drug prescription in hospitals on the basis of hospINDEX® data.

Chronic kidney disease (CKD)

A slow, progressive loss of renal function, over months or years. 

Climate disclosure scoring

Indicates the completeness of reporting to the Carbon Disclosure Project and the usefulness of the data.

CMS (content management system)

The development and digital management of content from initial creation to archiving or deletion.


Galenica efficiency improvement programme in which various IT infrastructures in the Logistics, Retail and HealthCare Information Business sectors are standardised and consolidated in a data centre in Niederbipp.

Comité des Jeunes

 A Galenica advisory committee composed of young staff members from the Galenica Group.


New editorial system for the Swiss Drug Compendium (Arzneimittel-Kompendium der Schweiz®); developed and distributed by HCI Solutions.


The willingness of patients to follow medical instructions. With regard to taking medications, following a diet or making life-style changes, compliance is particularly important for individuals suffering from chronic diseases or psychological disorders.


Vifor Pharma study investigating the effect of intravenously administered ferric carboxymaltose in patients with chronic heart failure and iron deficiency.

Consumer Healthcare Products

Non-pharmaceutical healthcare products sold directly to the consumer in pharmacies and Drugstores (OTC), for example Anti-Brumm®.

Decentralised procedure

A specific drug authorisation process in Europe.


The branch of medicine that deals with the diagnosis, treatment and care of patients with non-infectious and infectious skin diseases as well as benign and malignant skin tumours.

SDC (Swiss Agency for Development and Cooperation)

Swiss federal authority responsible for the country’s involvement in international collaborations, development activities and humanitarian assistance. Administratively subordinate to the Federal Department of Foreign Affairs.


A blood cleansing process used in cases of kidney failure, also called haemodialysis.


An exclusive service provided by Amavita pharmacies specifically to diabetics; includes therapy support enabling patients to have their blood sugar levels checked and documented, for example.


Synthetic drug for the prevention and treatment of capillary haemorrhages, a circulatory disorder; developed and marketed by OM Pharma.

Direct Healthcare Professional Communication (DHPC)

Risk information provided to medical professionals.


Docupass is a care dossier containing details of personal preferences, needs, requirements and

requests covering illness, healthcare, dying and death, offered by Coop Vitality in collaboration with Pro Senectute.


Synthetic drug to normalise capillary permeability and improve venous blood flow; developed and marketed by OM Pharma.

DRG (Diagnosis Related Groups)

Economic and medical classification system used to determine flat-rate payments for hospital treatment.

E-vaccination card

The Coop Vitality digital vaccination card provides secure access to your own vaccination data and can be programmed to inform the holder when vaccinations need to be renewed.

ECCO (European Crohn's and Colitis Organisation)

European organisation for Crohn's disease and ulcerative colitis (inflammation of the colon). 


Federal Department of Home Affairs (Eidgenössisches Departement des Innern). 

ERA-EDTA (European Renal Association and European Dialysis and Transplant Association)

The association of European kidney specialists, thus an association of physicians with over 7’000 members.

EEV emission standard

The voluntary EEV emission standard (Enhanced Environmentally Friendly Vehicle) is an emission standard for vehicles that produce lower emissions than the currently valid Euro 5 emission standard without increased fuel consumption.

EFFECT study Ferinject®

Study of the effects of intravenously administered iron on the mobility and quality of life of patients with chronic heart failure and iron deficiency.


A general term for IT-supported networking efforts in the healthcare industry.

Iron deficiency anaemia

Anaemia due to iron deficiency: the production of haemoglobin, the red pigment in the blood, is disrupted by the lack of iron. Iron deficiency anaemia is the most common form of anaemia throughout the world. According to the World Health Organization (WHO), two billion people suffer from iron deficiency anaemia worldwide.

Iron deficiency syndrome

A mild form of iron deficiency characterised by symptoms such as fatigue and exhaustion, irritability, paleness and brittle nails.

FCOS (Federal Coordination Commission for Occupational Safety)

Central information and coordination authority for occupational safety and health. Coordinates preventative measures, responsibilities for enforcement and the uniform application of regulations in Switzerland.

EMA (European Medicines Agency)

Agency responsible for the assessment and monitoring of medications in the European Union. Plays a central role in the authorisation of medications in the European Union and the member states of the European Economic Area. The European Commission approves or rejects marketing authorisation applications based on the EMA’s scientific evaluation.


Electronic access for doctors, pharmacies and hospitals to a platform containing information on medication for patients.

EPO (erythropoietin)

A hormone that promotes the formation of red blood cells. Classified as an erythropoiesisstimulating agent (ESA).

ERP (Enterprise Resource Planning)

Planning and managing resources such as capital, personnel, equipment, material, information and communication technology and IT systems in a timely and appropriate manner, in line with the company’s purpose. SAP is one example of such an ERP system. 

ERS (European Respiratory Society)

Society which researches respiratory diseases and promotes lung health.


Process by which red blood cells (erythrocytes) are produced.

ESA (erythropoiesis-stimulating agents)

Group of hormones that promote the formation of red blood cells, the most important of which is EPO (erythropoietin).

EVE (EVEnts)

A series of professional development events for members of the senior management (MDI) and management (MKA) of the Galenica Group, organised within the framework of the company’s Corporate Management Development (CMD) programme.


Liquid/roller to treat fungal nail infections. Excilor® is available as a handy applicator pen and in a solution bottle with brush. 

FAB (management training)

A series of management-based professional development courses for members of the Galenica Group’s senior management (MDI) and management (MKA), offered within the framework of the company’s Corporate Management Development (CMD) programme.

FAIR-HF study

Ferinject® Assessment in patients with IRon deficiency and chronic Heart Failure; a major, multi-centre, randomised, double-blind, placebo-controlled study that examined whether correction of iron deficiency with Ferinject® could improve patient health.

FDA (Food and Drug Administration)

US food supervision and drug regulation authority responsible for protecting public health in the USA.


FERinject® in GastroIntestinal disorders to CORrect iron deficiency; a major, multi-centre, randomised, prospective, comparative, open Phase III study that examined the efficacy, tolerability and safety of a simplified and standardised dosing scheme of Ferinject® in the correction of iron deficiency anaemia in patients with inflammatory bowel disease.


A follow-on from the FERGI-COR study.

Ferinject® / Ferric Carboxymaltose (FCM)

An innovative iron replacement product for the intravenous treatment of iron deficiency; developed and produced by Vifor Pharma.

FCM: Ferric carboxymaltose (Ferinject®), a novel iron complex that consists of a ferric hydroxide core stabilised by a carbohydrate shell, allows for controlled delivery of iron to target tissues. Administered intravenously, it is effective in the treatment of iron-deficiency anaemia, delivering a replenishment dose of up to 1000 mg of iron during a minimum administration time of </=15 minutes.

FERRIM study

A randomised, multi-centre, double-blind, placebo-controlled Phase III study in non-anaemic patients with iron deficiency and fatigue symptoms. The first study to investigate whether correction of iron deficiency with Venofer® is beneficial to patients with iron deficiency and fatigue symptoms.

Film-coated tablet

A tablet coated with only a single thin film. Unlike a sugar-coated tablet, a film-coated tablet is coated with a polymer rather than sugar.

FIND-CKD study

A clinical study examining the benefits of Ferinject® over oral iron replacement products for the treatment of anaemia in patients with chronic kidney disease (without dialysis).


The term environmental footprint defines how much of the Earth’s surface it would take to Support humanity over the long term with a given lifestyle and standard of living.

Photovoltaic plant

Solar power plant in which some of the sun’s rays are converted to electrical energy using solar cells.


FPH, which stands for Foederatio Pharmaceutica Helvetiae (Swiss Association of Pharmacists), is also a professional title used in general and clinical pharmacy in Switzerland that is analogous to the FMH title for physicians.


A commercial and scientific database of around 200,000 pharmaceutical and non pharmaceutical products. It includes reference data in a standardised and uniform structure for all IT systems in the Swiss healthcare industry – for pharmacies, physicians, hospitals and health insurers; galdat® forms the basis of all Index products. Developed and sold by HCI Solutions.

GAL e-Learn

An online training platform for customers (particularly pharmacies); developed and distributed by Galexis.


The brand name of a line of products from Galexis.


Pharmaceutical technology for preparing the dosage form of medications (e.g. tablets or injection solutions).


The branch of internal medicine that deals with the gastrointestinal tract or digestive system.

Vascular check

The Galexis vascular check allows pharmacists to give customers important information about the condition of their blood vessels within five minutes.


A drug that contains the same active ingredient as a brand-name pharmaceutical product (originator product) already on the market. Generics can differ from the originator products with respect to non-active ingredients and manufacturing technologies.

GEP (Galenica Economic Profit)

An internally defined parameter used in capital management and capital employment based on income components, free cash flow components and invested capital. The goal of the Galenica Group is to achieve a sustainable increase in GEP in all Business sectors.


Overview of the “Federal Council’s Health Policy Priorities".


Ginsana® is the completely natural energy source to combat tiredness, weakness and exhaustion.
Ginsana® products contain only G115® standardised ginseng extract obtained from the roots of panax ginseng. 

Global Compact

An international initiative of the United Nations and participating corporations established to achieve socially responsible and environmentally compatible globalisation.

Global Reporting Initiative (GRI 3)

An international organisation established by investors and environmental organisations in partnership with the United Nations Environment Programme (UNEP); it develops guidelines, through a participatory process, for the preparation of sustainability reports by companies, governments and NGOs.


Rapid blood test for gluten intolerance. 

Good Distribution Practice (GDP)

Guidelines for good logistics practice followed by Switzerland, the EU and the FDA for quality assur-ance in the storage, handling and shipment of pharmaceuticals, active substances and other medicinal products.

Good Manufacturing Practice (GMP)

Guidelines issued by the EU and the FDA for quality assurance in the production of pharmaceuticals, active substances and other medicinal products.


The branch of medicine concerned with women’s health issues.


A cardiovascular check-up and individual risk profile (heart passport) offered by GaleniCare in its pharmacies in cooperation with the Swiss Heart Foundation.

Heart failure

Heart failure can lead to impaired performance in persons affected due to a lack of oxygen and blood supply to the organs.


The branch of medicine concerned with the physiology, pathophysiology and diseases of the blood and blood-forming organs. It includes, for example, malignant blood diseases and diseases of the bone marrow.


Health Maintenance Organization.


A blood cleansing process used in the treatment of kidney diseases.


Iron-rich protein that transports oxygen; found in the red blood cells.

Home nurses

Qualified nursing professionals with specific additional training in home nursing; a form of patient care offered by MediService in conjunction with Pharma Care.


A medical database for all processes such as logistics, invoicing and prescription that replaces galdat® in hospitals; developed and distributed by HCI Solutions.


Excessively active behaviour that cannot be adequately controlled by the person affected. Also referred to as attention deficit disorder (ADD).


Potentially life-threatening condition defined as abnormally elevated levels of potassium in the blood. Hyperkalaemia occurs most frequently in chronic kidney disease patients (CKD),  heart failure patients (HF) and patients who suffer from hypertension or diabetes.


An abnormally high serum phosphate level.


High blood pressure


Low blood pressure.

IAS 19

Accounting requirements for employee benefits.


An active ingredient that relieves pain, reduces fever and is anti-inflammatory.


International Financial Reporting Standards.


The science concerned with the biological and biochemical principles of the body’s defence against pathogens, such as bacteria, viruses and fungi, and other foreign substances such as biological poisons.


Biological products based on bacterial lysates to strengthen the body's immune system again recurring respiratory or urinary tract infections.


The prevention of infectious diseases via the stimulation of the immune system.

IMS Health

An international consulting and market research company based in Hergiswil, Switzerland, that is active in the pharmaceutical sector.


A reason for a medical treatment or procedure.


Brand name of Ferinject® in the USA and Belgium.


A database for cost units in the healthcare sector that replaces galdat® in health insurance companies; developed and distributed by HCI Solutions. 

Intravenous (i.v.)

A term referring to the administration of a medication or a liquid directly into a blood vessel.

ISS (iron sucrose similar)

Intravenous iron sucrose is used to treat iron deficiency. Copies of the complex structure of iron sucrose are called iron sucrose similars.


The branch of medicine dealing with the heart and cardiovascular diseases.

Key Performance Indicator (KPI)

A measurement of performance in terms of progress made or level of achievement with regard to important objectives.

Kidney Disease: Improving Global Outcomes (KDIGO)

Global foundation to improve the care and treatment outcomes of patients with kidney disease worldwide.

Clinical development/clinical studies

Trials carried out as part of the development process for new drugs in which the drugs are extensively tested as to their efficacy and safety. The clinical study programme is broken down into several phases.

Cognitive disorder

Disruption of the processing of sensory impressions (as in hyperactivity) that may lead to learning difficulties, inattentiveness, etc. 

Green Code of Conduct

Internal guidelines aimed at promoting ecological behaviour (Code of Conduct).


Skincare brand of the Alès Group. 

Life cycle management

Refers to a strategic concept for managing a product throughout its entire life cycle.

Service-based remuneration (SBR)

The agreement between santésuisse (the Swiss Association of Health Insurers) and pharmaSuisse (formerly the Schweizerische Apothekerverband – the Swiss Association of Pharmacists), under which a pharmacy’s income is no longer linked to the product price.


Database for wholesalers in the Swiss healthcare industry which contains information on approximately 180,000 items. Developed by, and available through, HCI Solutions.

Third-party logistics service

Extensive offering that enables customers and suppliers to transfer their logistics (both bulk and dispersion) to the Logistics Business sector.

LTI programme (Long-term Incentive Programme)

Share-based profit-sharing bonus programme for members of the Corporate Executive Committee and certain members of management.


The internal Galenica LoRe (Logistics-Retail) project should improve product availability. It also aims to give pharmacy employees more time for customer service.

Magnesium® Vital

A magnesium replacement product for cramps in the calf muscles; developed and distributed by Vifor Pharma.


An oral iron replacement product for the treatment of iron deficiency that is sold worldwide; developed and produced by Vifor Pharma.

Managed Care

A healthcare management model. The Managed Care model incorporated into the revision of the Swiss Federal Health Insurance Act is intended to promote integrated healthcare networks and improve ability to offset risk.

Marketing Authorization Application MAA

Marketing authorization application submitted to the European Medicines Agency (EMA). 


Member of senior management of the Galenica Group.

Medical affairs

A general term covering the following activities: contact with physicians who are opinion leaders, planning and coordination of clinical trials, interface between marketing and medicine, medical-scientific training and continuing education for sales representatives.

MHRA (Medicines and Healthcare Products Regulatory Agency

Licensing and regulatory body for medicines in the UK.

Medication check

A service provided by pharmacists under the service-based remuneration (SBR) agreement; includes remuneration for checking prescriptions, checking for interactions (compatibility with other medications), writing instructions for use, etc.


A medical database that replaces galdat® in medical practices; developed and sold by HCI Solutions.

Web-based information platform for doctors in private practice and those working in hospitals which complements medINDEX®.

Medical technology

Equipment and technical procedures used in medical practices and laboratories. 


An oral magnesium replacement product for the treatment of magnesium deficiency; distributed by Vifor Pharma.


Mircera® is a prescription medicine used to treat symptomatic anaemia associated with chronic kidney disease (CKD) in adult patients.
Galenica and Roche have entered into an exclusive licensing agreement for the marketing and distribution of the Roche Mircera® product in the USA and Puerto Rico. 


Member of the management of the Galenica Group. 

Mutual recognition procedure

Procedure that allows member states of the European Union to approve decisions about a medicinal product, such as a marketing authorisation, that have been decided by another EU country.


Pharmaceutical database with information about a patient’s drug therapy which is part of the pharmacy management tool TriaPharm®.


A moisturising nasal spray produced and distributed by Vifor Pharma.


Non-dialysis-dependent chronic kidney disease.

NDA (New Drug Application)

The NDA is the official means by which manufacturers of pharmaceutical products in the USA apply to the FDA for approval to market a drug in the USA.


The branch of medicine dealing with the kidney and with the diagnosis and treatment of kidney diseases.


A project initiated by pharmaSuisse, the Swiss pharmacy association, and a health insurer, whereby physicians can speak to pharmacists and patients via a screen.


The branch of medicine concerned with diseases of the nervous system. 

Chronic kidney disease (CKD)

A slow, progressive loss of renal function, over months or years.


Brand name of the oral iron replacement product Maltofer® in Brazil.


An invoicing system for Galexis customers.

Certified general pharmacist

Pharmacist who manages or works in a dispensary.

OID (object identifiers)

Unique numerical codes that permit objects to be identified simply. OIDs are useful when creating electronic registers for eHealth systems.


Payment control function of the pharmacy management tool TriaPharm®.


Function of the pharmacy management tool TriaPharm® that supports invoicing to health insurers. 


The branch of medicine concerned with cancers that affect the blood system.


The branch of medicine that deals with cancer.

Operational Excellence (OPEX)

When implementing OPEX, companies apply it to their entire strategy, continually and dynamically optimising all processes and systems along the value chain. 


The branch of medicine concerned with the anatomy, functions, pathology and treatment of the eye.


The Galenica Group employee survey.


A term referring to a medication ingested through the mouth.


A disease (of old age) involving a greater vulnerability to bone fracture due to an overly rapid reduction in bone mass; often associated with calcium deficiency.


Phosphate binder for the treatment of elevated phosphate levels in patients with chronic kidney disease who are undergoing dialysis (haemodialysis or peritoneal dialysis).
Marketed by Vifor Fresenius Medical Care Renal Pharma. 


A product for the treatment of earache and inflammation of the eardrum; produced and distributed by Vifor Pharma.

OTC products

Over-the-counter products, a term used to refer to medicines available without a prescription (Consumer Healthcare products).

OTX products

OTX medications are drugs which are not prescription-only, but are nonetheless largely prescribed by doctors; they are not always reimbursed by health insurers.


Products such as wound dressings that are sold along with pharmaceuticals but do not meet the legal definition of a pharmaceutical.

Parcel Service

Transport of parcels to and between Galexis customers, performed along with regular deliveries by Galexis.


A term referring to administration of a medicine by a route other than the gastrointestinal tract; generally by infusion (such as with Venofer®), injection, through the skin (transdermal) or mucous membranes.

Pemphigus vulgaris

An autoimmune disease in which the immune system produces antibodies against certain proteins of the skin and the mucous membranes.

PEP (Personaleinsatzplanung)

Staff resource planning: new IT system for recording time and planning staff resources in pharmacies.

Performance units

Performance-related measurement unit used in the Long-term Incentive Programme


A product line that provides relief from aching muscles and joints; manufactured and distributed by Vifor Pharma.

Pharma Care

Comprehensive medical in-home care of patients with chronic and rare diseases; provided by MediService.


Stands for the ongoing, systematic monitoring of the safety of a drug with the objective of identifying and assessing any undesirable effects in order to take measures to minimise the risk.


Physicians wholesaler, supplies and supports medical practices with medications, consumables, laboratory products and furnishings. 


An Internet-based product information platform developed and sold by HCI Solutions. 


Phosphate binder for the treatment of elevated phosphate levels in patients with chronic kidney disease who are undergoing dialysis (haemodialysis or peritoneal dialysis).
Marketed by Vifor Fresenius Medical Care Renal Pharma. 


Haircare products of the Alès Group. 


The science that deals with the effects and manufacture of plant-based pharmaceuticals.

Pick-by-light system

Logistics system in which a beam of light guides staff working in order picking to the location where they can collect the product. 

Polymedication check

A compliance-related check by the pharmacist to ascertain whether various medicines being taken simultaneously by the patient are tolerated in combination. 


The stage of renal insufficiency prior to commencement of dialysis

PREFER study

Clinical study with Ferinject® in women with iron deficiency without anaemia which aims to confirm the results of the FERRIM study in a larger number of patients. 


The prewholesaler operates the warehouse logistics based on the guidelines of the producer at the producer’s expense. In other words: warehouse logistics are being outsourced. For example, Alloga in the Galenica Group.

Process management

The design and management of entire processes.

Process One

Quality management system developed by Winconcept for independent pharmacies. 


A logistics system for pharmaceutical companies’ promotional materials; marketed by Galexis.

QMS (quality management system)

Quality management systems ensure that the system quality, process quality and product quality in an organisation are checked and improved. The aim of a quality management system is to permanently improve a company’s performance.


Product for the treatment of Secondary Hyperparathyroidism in patients with Chronic Kidney Diseases. Is being developed and commercialised by Vifor Pharma with OPKO Health. 

Regulatory affairs

A general term for the activities that are required in order to obtain approval from the authorities for the development, manufacture, marketing and distribution of pharmaceuticals. 


Brand name of Ferinject® in Latin American countries.


Epoetin alfa biosimilar by Pfizer. 

Extended-release form

A dosage form in which the pharmaceutical substance is released slowly over an extended period.


The branch of medicine dealing with the diagnosis and treatment of chronic diseases which mostly become evident through musculoskeletal pain.


The market launch of a product or service. The term refers primarily to technical applications. 


A designation for prescription drugs or medicines.

SAM (special staff training)

A series of training seminars for new employees focused on processes and personal development, offered within the framework of the Corporate Management Development (CMD) programme.

Schuessler salts

Schuessler salts are alternative medical products made from mineral salts in homeopathic doses (potentiation). 

SECO (State Secretariat for Economic Affairs)

The State Secretariat for Economic Affairs is responsible for creating the regulatory and economic policy conditions for sustainable economic growth. SECO is an office of the Federal Department of Economic Affairs.


Direct dispensation of medicines by physicians.


With the web-based system Senaca®, MediService helps patients to adapt their lifestyle in a structured and scheduled manner. 

Serum phosphorus level

Concentration of phosphorus in the blood.

Serum ferritin

Iron content in the blood.


An active ingredient from the phosphate binder group, which is used in dialysis patients with hyperphosphataemia to bind dietary phosphates. 


Sorbisterit® is a preparation that can be administered orally or rectally in the event of an increase in blood potassium levels in acute or chronic kidney failure.
Marketed by Vifor Fresenius Medical Care Renal Pharma. 

Specialty Pharma, a strategic area

The strategic focus by the Galenica Group on the development, production and sale of its own medicines in international markets, particularly products for iron deficiency, as well as its own infectious diseases/OTX and OTC products. 


A service that provides information on products and on scientific and non-scientific questions from pharmacies and drugstores; operated by HCI Solutions. 

Swiss HealthCare Services, a strategic area

The focus by the Galenica Group on a business model providing services for the Swiss healthcare market. This model integrates the Amavita, Sun Store, Coop Vitality, MediService and Winconcept pharmacy formats, logistics services and information management.


The Swiss Agency for Therapeutic Products; the regulatory agency for medicines and medical devices based in Bern. No pharmaceutical products for humans or animals may be marketed in Switzerland until they have been licensed by Swiss-medic. All clinical trials in Switzerland must also be approved by Swissmedic.


A gingko-based product for the treatment of age-related impaired cerebral blood flow, for enhancing the power of concentration and for increasing memory retention; developed and distributed by Vifor Pharma. 


Skincare products for tattooed skin. 

Tecfidera® (BG-12)

Medication produced by Biogen Idec for the treatment of relapsing-remitting multiple sclerosis and rheumatoid arthritis. Manufactured by Vifor Pharma in Switzerland under contract. 

Technical room

Explosion-proof storage room for technically and chemically demanding products such as sprays and medicines containing alcoholic solvents. 


Medical diagnosis and therapy via telecommunications.

Top Homecare

A sales and consulting concept in the homecare area for pharmacies and drugstores; developed and marketed by Galexis.

Toxicity profile

Profile of the toxicity of a substance. Determinations of toxicity are generally made in animal studies.


Platform developed by HCI Solutions for direct invoicing between pharmacies and health insurers. 


A management software solution for medical practices; developed and marketed by HCI Solutions. 

TriaMed® Box

A small computer, fully preconfigured with TriaMed®. An entry product launched by HCI Solutions.

TriaMed TS®

Management software for medical practices which runs via an external server of HCI Solutions; developed and sold by HCI Solutions. 


Integrated administrative solution with complete coverage of all necessary functionalities of a company (ERP); based on the former product Arizona, developed by BMC. 


A management software solution for pharmacies; developed and marketed by HCI Solutions. 


Expansion software from TriaPharm® to scan in and digitise prescriptions; developed and marketed by HCI Solutions.


Nasal spray for colds, the leading product of its type in Switzerland; produced and sold by Vifor Pharma.

Corporate Management Development (CMD)

CMD includes all the staff development activities that Galenica offers to employees and managerial staff.


Biotech drug for the prevention and alleviation of urinary tract infections; developed and marketed by OM Pharma.

Value-based management

A management approach that ensures that companies are focused on improving enterprise value (corporate value). 

Velphoro® (PA21)

Iron-based phosphate binder used to control serum phosphorus levels in patients with dialysis-dependent chronic kidney disease (CKD). Developed and produced by Vifor Pharma; distributed by Vifor Fresenius Medical Care Renal Pharma. 

Veltassa® (Patiromer FOS)

Investigational medicinal product from Relypsa Inc. for the treatment of hyperkalaemia, which occurs most frequently in chronic kidney disease and heart failure patients. 


An intravenous product for the treatment of iron deficiency; developed and produced by Vifor Pharma and sold worldwide. 

Blister packaging

Packaging of medications in portions arranged in rows – like a rolled film strip; service offered by Medifilm to care homes. Increases safety in taking medications, improves therapy compliance and decreases the workload of staff in care homes. 

Code of Conduct

A collection of the principles of conduct that are to be followed in specific situations and consequently promote uniform conduct by groups of individuals within the corporation.


The VERIFIE (Phase IV) program has been initiated in 2016 and will allow to follow the use of Velphoro® in real life in Europe. 


A small bottle with various types of closure (e.g. capsule closure with a membrane for piercing). 

Vitafor® probi-immun®

Swedish probiotic prevention treatment against colds.
Marketed by Vifor Consumer Health. 


Volatile organic compounds; a collective term for organic i.e. carbon-containing substances that evaporate easily and are present as a gas at low temperatures. Term used primarily in connection with air pollutants.


The Swiss Competition Commission. 


Link between the various stages of distribution; purchases goods that it does not generally process or manufacture itself (merchandise) and distributes these to processing, retail, industrial or other commercial companies, etc. For example, Galexis and Unione Farmaceutica Distribuzione in the Galenica Group.


The World Health Organization of the United Nations, based in Geneva, Switzerland. 


The World Trade Organization is an international organisation headquartered in Geneva that regulates trade and economic relations.

Cystic fibrosis

Also known as mucoviscidosis, is a congenital metabolic disease that causes chronic coughing and frequent lung infections due to viscous mucus in the bronchial tubes.


Naturally occurring or artificially produced substances that inhibit cell growth and division. Used primarily in the treatment of cancer (chemotherapy) or autoimmune diseases.

Send link

Send as link